FLCGX
Price
$40.02
Change
+$0.22 (+0.55%)
Updated
Jul 31 closing price
Net Assets
44.75M
RGWBX
Price
$29.76
Change
+$0.31 (+1.05%)
Updated
Jul 31 closing price
Net Assets
28.22B
Interact to see
Advertisement

FLCGX vs RGWBX

FLCGX vs RGWBX Comparison Chart in %
View a ticker or compare two or three
VS
FLCGX vs. RGWBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLCGX is a Buy and RGWBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGWBX has more cash in the bank: 28.2B vs. FLCGX (44.7M). FLCGX pays higher dividends than RGWBX: FLCGX (0.54) vs RGWBX (0.00). FLCGX was incepted earlier than RGWBX: FLCGX (41 years) vs RGWBX (14 years). FLCGX (1.74) is less costly to investors than RGWBX (1.46). FLCGX is a more actively managed with annual turnover of: 170.00 vs. RGWBX (1.00). RGWBX has a lower initial minimum investment than FLCGX: RGWBX (250) vs FLCGX (2500). RGWBX annual gain was more profitable for investors over the last year : 10.02 vs. FLCGX (7.45). RGWBX return over 5 years is better than : 16.76 vs. FLCGX (-2.30).
FLCGXRGWBXFLCGX / RGWBX
Total Expense Ratio1.741.46119%
Annual Report Gross Expense Ratio1.741.46119%
Fund Existence41 years14 years-
Gain YTD6.2377.98378%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets44.7M28.2B0%
Annual Yield % from dividends0.540.00-
Returns for 1 year7.4510.0274%
Returns for 3 years14.5444.5933%
Returns for 5 years-2.3016.76-14%
Returns for 10 years39.9799.9040%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LMUB49.66-0.05
-0.10%
iShares Long-Term National Muni Bd ETF
MIG20.92-0.06
-0.27%
VanEck IG Corporate ETF
HOLA56.05-0.20
-0.36%
JPMorgan Intl Hdg Eq Ldrd Overlay ETF
BTZ9.97-0.05
-0.50%
BlackRock Credit Allocation Income Trust
IDNA32.33-0.46
-1.40%
iShares Genomics Immnlgy & Hlthcr ETF